Literature DB >> 15000878

Mechanism underlying blockade of voltage-gated calcium channels by agmatine in cultured rat hippocampal neurons.

Jian-quan Zheng1, Xie-chuan Weng, Xiao-dan Gai, Jin Li, Wen-bin Xiao.   

Abstract

AIM: To investigate whether agmatine could selectively block a given type of the voltage-gated calcium channels (VGCC) and whether related receptors are involved in the blocking effect of agmatine on VGCC.
METHODS: The whole-cell patch recording technique was performed to record VGCC currents in the cultured neonatal rat hippocampal neurons.
RESULTS: Verapamil (100 micromol/L), a selective blocker of L-type calcium channel, significantly inhibited VGCC current by 80 %+/- 7 %. Agmatine (100 micromol/L) could further depress the remained currents by 25 %+/-6 %. The alpha 2-adrenoceptor antagonist yohimbine (10 micromol/L) and the I2 imidazoline receptor antagonist idazoxon (10 and 40 micromol/L) had no significant effect on VGCC currents when used respectively. When the mixture of yohimbine and agmatine was applied, VGCC currents were still depressed remarkably. However, the blocking effect of agmatine was decreased by 29 %+/- 8 % in the presence of idazoxon (10 micromol/L). The effect of idazoxon did not increase at a higher concentration (40 micromol/L).
CONCLUSION: Agmatine could block the L- and other types of VGCC currents in the cultured rat hippocampal neurons. Blocking effect of agmatine on VGCC was partially related to I2 imidazoline receptor and had no relationship with alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000878

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  12 in total

Review 1.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

2.  Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons.

Authors:  M-Y Zhu; W-P Wang; G Bissette
Journal:  Neuroscience       Date:  2006-06-13       Impact factor: 3.590

Review 3.  Agmatine: biological role and therapeutic potentials in morphine analgesia and dependence.

Authors:  Soundar Regunathan
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

4.  Dexmedetomidine and clonidine inhibit the function of Na(v)1.7 independent of α(2)-adrenoceptor in adrenal chromaffin cells.

Authors:  Toyoaki Maruta; Takayuki Nemoto; Shinya Satoh; Tasuku Kanai; Toshihiko Yanagita; Akihiko Wada; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-05-24       Impact factor: 2.078

5.  An Imidazoline 2 Receptor Ligand Relaxes Mouse Aorta via Off-Target Mechanisms Resistant to Aging.

Authors:  Francesc Jiménez-Altayó; Anna Cabrera; Andrea Bagán; Lydia Giménez-Llort; Pilar D'Ocon; Belén Pérez; Mercè Pallàs; Carmen Escolano
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

6.  Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure.

Authors:  B Lewis; K A Wellmann; S Barron
Journal:  Pharmacol Biochem Behav       Date:  2007-07-25       Impact factor: 3.533

Review 7.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Zheng-Wei Cai; Soundar Regunathan; Gregory Ordway
Journal:  Eur J Neurosci       Date:  2008-03       Impact factor: 3.386

Review 9.  Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence.

Authors:  Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2007-07-25       Impact factor: 5.046

10.  Repeated immobilization stress alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels.

Authors:  Meng-Yang Zhu; Wei-Ping Wang; Jingjing Huang; Yang-Zheng Feng; Soundar Regunathan; Garth Bissette
Journal:  Neurochem Int       Date:  2008-09-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.